male infertility

Male infertility is a common cause of infertility among couples and contributes to nearly 40–50% of infertility cases worldwide. Accurate diagnosis and appropriate treatment play a crucial role in achieving natural pregnancy or improving the success of assisted reproductive technologies. This article reviews the main methods for diagnosis and treatment of male infertility based on the recommendations of the World Health Organization (WHO).

Semen Analysis

The cornerstone of diagnosing male infertility is semen analysis. This test evaluates key parameters such as sperm concentration, motility, morphology, and semen volume.

WHO Recommendations for Repeating Semen Analysis

  • For men in infertile couples who have one or more semen parameters outside WHO reference ranges, WHO recommends repeating semen analysis after at least 11 weeks.
  • For men whose semen parameters are entirely within WHO reference ranges, WHO suggests that repeat semen analysis is not necessary.

🔹 The latest WHO Laboratory Manual for the Examination and Processing of Human Semen provides standardized reference values and detailed protocols for semen collection and analysis, ensuring accurate diagnosis of male infertility.

Unexplained-Factor Infertility

When Is Unexplained Infertility Diagnosed?

WHO suggests diagnosing unexplained-factor infertility in a couple when all of the following conditions are met:

  • Failure to achieve pregnancy after 12 months of regular, unprotected sexual intercourse;
  • Normal medical history and physical examination in both partners;
  • Evidence of ovulation and tubal patency in the female partner;
  • Semen parameters within WHO reference ranges in the male partner.

In these cases, no obvious cause of male infertility or female infertility can be identified despite thorough evaluation.

Treatment Options for Male Infertility

Use of Antioxidant Supplements

For men with male infertility who have one or more abnormal semen parameters and are attempting conception—either naturally or through assisted reproductive technologies (ART)—the WHO Guideline Development Group does not make a recommendation for or against the use of antioxidant supplements.

🔹 While adequate nutrition during the preconception period is important for both partners, the specific benefits of antioxidant supplementation in men with defined male infertility pathologies remain uncertain.

Varicocele and Male Infertility

Indications for Varicocele Treatment

For men with:

  • Diagnosed male infertility,
  • Clinically detectable varicocele,
  • Abnormal semen parameters,

WHO suggests that surgical or radiological treatment of varicocele should be preferred over expectant (no-treatment) management.

🔹 Men with clinical varicocele and abnormal semen analysis are more likely to benefit from treatment compared to those with normal semen parameters. These recommendations apply to men who are not undergoing ART.

Choice of Varicocele Treatment Method

WHO recommends either:

  • Surgical treatment, or
  • Radiological treatment (embolization)

The choice of treatment should consider:

  • Feasibility of the procedure,
  • Availability of trained healthcare providers,
  • Patient preference.

Surgical Management of Varicocele

For men undergoing surgical treatment of varicocele, WHO suggests the use of microsurgical techniques rather than non-microsurgical approaches.

🔹 Microsurgical subinguinal varicocelectomy is the most commonly recommended technique due to lower complication and recurrence rates.

If microsurgical expertise is unavailable, alternative methods may be used, including:

  • Non-microsurgical open approaches (inguinal or retroperitoneal),
  • Laparoscopic surgery.

These recommendations apply to infertile men with varicocele who are not using ART.

First-Line Management of Unexplained Infertility

Expectant Management

For couples diagnosed with unexplained infertility, WHO suggests expectant management over unstimulated intrauterine insemination (IUI).

Expectant management includes:

  • Lifestyle counseling,
  • Education about the fertile window,
  • Regular follow-up without medical intervention.

⏱ In most studies, the duration of expectant management ranged from 3 to 6 months.

The diagnosis and treatment of male infertility require a systematic and evidence-based approach. Semen analysis remains the primary diagnostic tool, while treatment strategies should be tailored to the underlying cause. Following WHO guidelines helps optimize outcomes and improves the chances of successful conception.